IMRX Financials
Immuneering Corp - Financial statements & key metrics
Stock Price
$5.70
Market Cap
$356.88M
EPS
$-1.27
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-61.04M
EPS (Diluted)
$-2.04
Balance Sheet Highlights
Total Assets
$52.71M
Total Liabilities
$11.33M
Shareholders Equity
-
Cash & Equivalents
$36.14M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-55.00M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
34907.7%
ROE
-0.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is IMRX revenue?
View IMRX's income statement for detailed revenue data.
Is IMRX profitable?
IMRX reported a loss of $61.04M in the most recent quarter.
What is IMRX market cap?
IMRX has a market capitalization of $356.88M, making it a small-cap stock.
Does IMRX have debt?
View IMRX's balance sheet for debt information.
What is IMRX cash flow?
Cash flow data is available in the full financial statements.